14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ETRM
Delisted

EnteroMedics Inc. Fund Predictions

$2.05
+0 (+0%)
At Close: Jan 16, 2018
Currently predicting for Mon, 20 May 2024

ETRM Predictions History

7 years ago
Abdu predicted that ETRM for 2016-11-28 is going $0.0710 (-98.55%)

7 years ago
JS predicted that ETRM for 2016-11-28 is going $0.0690 (-98.77%)

7 years ago
JS predicted that ETRM for 2016-11-02 is going $0.0780 (-98.41%)

7 years ago
JS predicted that ETRM for 2016-10-31 is going $0.0970 (-98.27%)

7 years ago
JS predicted that ETRM for 2016-10-26 is going $0.0980 (-98.60%)

7 years ago
JS predicted that ETRM for 2016-10-24 is going $0.114 (-98.52%)

7 years ago
Firas.Babar.1378 predicted that ETRM for 2016-10-24 is going $0.183 (-97.62%)

Rank:

7 years ago
Sean.Yang.1188 predicted that ETRM for 2016-10-06 is going $0.444 (-95.12%)

Rank:

7 years ago
JS predicted that ETRM for 2016-10-06 is going $0.128 (-98.59%)

7 years ago
Ranga.Ravikumar.1119 predicted that ETRM for 2016-10-03 is going $0.300 (-96.94%)

Rank:
Click to get the best stock tips daily for free!

About EnteroMedics Inc.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sens... ETRM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT